{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:06:06Z","timestamp":1767992766393,"version":"3.49.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>An elevated fibrinogen level has been demonstrated to be a predictor of adverse coronary heart disease outcome. This study aimed to assess whether fibrinogen is a useful marker to predict the prognosis of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) undergoing percutaneous coronary intervention (PCI). Additionally, the prognostic accuracy of fibrinogen level was compared with that of the Global Registry of Acute Coronary Events (GRACE) score.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 1211 patients with NSTE-ACS undergoing PCI were analyzed in a prospective cohort study. The enrolled patients were divided into a low fibrinogen group (<jats:italic toggle=\"yes\">n<\/jats:italic>\u2009=\u2009826, fibrinogen\u2009\u2264\u20093.49\u2009mg\/dl) and a high fibrinogen group (<jats:italic toggle=\"yes\">n<\/jats:italic>\u2009=\u2009385, fibrinogen\u2009&gt;\u20093.49\u2009mg\/dl) based on a receiver operating characteristic (ROC) curve. The clinical endpoints were death and death\/nonfatal reinfarction. An ROC curve analysis was performed and the area under the curve with a 95% confidence interval (CI) was derived and compared with those for the GRACE score to determine the diagnostic value of the serum fibrinogen level.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Multivariate analysis showed that an elevated baseline fibrinogen level was an independent predictor of death\/nonfatal reinfarction (hazard ratio\u2009=\u20091.498, 95% CI: 1.030\u20132.181, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.035). The prognostic performance of fibrinogen was equivalent to that of the GRACE system in predicting clinical endpoints (C-statistic: <jats:italic toggle=\"yes\">z<\/jats:italic>\u2009=\u20091.486, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.14).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Fibrinogen is an independent predictor of death\/nonfatal reinfarction in patients with NSTE-ACS undergoing PCI, and its accuracy is similar to that of the GRACE system.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000789","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T14:48:55Z","timestamp":1576248535000},"page":"124-129","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention"],"prefix":"10.1097","volume":"31","author":[{"given":"Jia","family":"Song","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongtong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxu","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230924","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"R3-20230924","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"R4-20230924","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1253\/circj.CJ-18-0063","article-title":"Inflammatory mechanisms of cardiovascular remodeling.","volume":"82","author":"Anzai","year":"2018","journal-title":"Circ J"},{"key":"R5-20230924","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jth.13919","article-title":"Platelet collagen receptor glycoprotein vi-dimer recognizes fibrinogen and fibrin through their d-domains, contributing to platelet adhesion and activation during thrombus formation.","volume":"16","author":"Induruwa","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R6-20230924","first-page":"13195","article-title":"Plasma fibrinogen lever and risk of coronary heart disease among chinese population: a systematic review and meta-analysis.","volume":"8","author":"Song","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R7-20230924","doi-asserted-by":"crossref","first-page":"e015041","DOI":"10.1136\/bmjopen-2016-015041","article-title":"Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.","volume":"7","author":"Yang","year":"2017","journal-title":"BMJ Open"},{"key":"R8-20230924","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12967-016-1006-6","article-title":"Fibrinogen consumption is related to intracranial clot burden in acute ischemic stroke: a retrospective hyperdense artery study.","volume":"14","author":"Pikija","year":"2016","journal-title":"J Transl Med"},{"key":"R9-20230924","doi-asserted-by":"crossref","first-page":"e006580","DOI":"10.1161\/JAHA.117.006580","article-title":"Elevated baseline serum fibrinogen: effect on 2-year major adverse cardiovascular events following percutaneous coronary intervention.","volume":"6","author":"Ang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R10-20230924","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2016.03.540","article-title":"Elevated serum fibrinogen is associated with 12-month major adverse cardiovascular events following percutaneous coronary intervention.","volume":"67","author":"Mahmud","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R11-20230924","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0300-8932(02)76670-0","article-title":"Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction.","volume":"55","author":"Arnau Vives","year":"2002","journal-title":"Rev Esp Cardiol"},{"key":"R12-20230924","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.amjcard.2016.02.032","article-title":"Effect of serum fibrinogen, total stent length, and type of acute coronary syndrome on 6-month major adverse cardiovascular events and bleeding after percutaneous coronary intervention.","volume":"117","author":"Mahmud","year":"2016","journal-title":"Am J Cardiol"},{"key":"R13-20230924","first-page":"36","article-title":"Serum fibrinogen and C-reactive protein levels predict major adverse cardiac events in unstable angina.","volume":"52","author":"Keshavamurthy","year":"2000","journal-title":"Indian Heart J"},{"key":"R14-20230924","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.75.4.817","article-title":"The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial.","volume":"75","author":"Sheehan","year":"1987","journal-title":"Circulation"},{"key":"R15-20230924","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2014.15095","article-title":"Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.","volume":"312","author":"Park","year":"2014","journal-title":"JAMA"},{"key":"R17-20230924","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R18-20230924","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"R19-20230924","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0002-9149(96)90386-0","article-title":"Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB trial).","volume":"78","author":"Becker","year":"1996","journal-title":"Am J Cardiol"},{"key":"R20-20230924","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/000331970605700304","article-title":"In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis.","volume":"57","author":"Ziakas","year":"2006","journal-title":"Angiology"},{"key":"R21-20230924","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2796.2003.01181.x","article-title":"Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis.","volume":"254","author":"Bennermo","year":"2003","journal-title":"J Intern Med"},{"key":"R22-20230924","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11239-011-0628-z","article-title":"Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention.","volume":"33","author":"Lupi","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"R23-20230924","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MCA.0000000000000295","article-title":"Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome.","volume":"27","author":"Celik","year":"2016","journal-title":"Coron Artery Dis"},{"issue":"Suppl A","key":"R24-20230924","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/eurheartj\/16.suppl_A.31","article-title":"Fibrinogen in ischaemic heart disease.","volume":"16","author":"Meade","year":"1995","journal-title":"Eur Heart J"},{"key":"R25-20230924","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0735-1097(98)00515-4","article-title":"Increased reactivity of platelets induced by fibrinogen independent of its binding to the iib-iiia surface glycoprotein: a potential contributor to cardiovascular risk.","volume":"33","author":"Schneider","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R26-20230924","first-page":"317","article-title":"Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction.","volume":"16","author":"Tatli","year":"2009","journal-title":"Cardiol J"},{"key":"R27-20230924","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2005.01.039","article-title":"Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction.","volume":"182","author":"Zairis","year":"2005","journal-title":"Atherosclerosis"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:04:44Z","timestamp":1695539084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000789","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}